Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Dingdang Health Technology GroupHKSE:09886 68 WACC % is 5.4% as of Aug. 27, 2026, which is 44% below its 10-year median of 9.63. GuruFocus rates HKSE:09886 with a GF Score™ of 68/100 and a GF Value™ of HK$1.44 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 692 Healthcare Providers & Services companies, Dingdang Health Technology Group ranks better than 71.1% on this metric.
As of today (2026-08-27), Dingdang Health Technology Group's weighted average cost of capital is 5.4%%. Dingdang Health Technology Group's ROIC % is -4.58% (calculated using TTM income statement data).
Dingdang Health Technology Group earns returns that do not match up to its cost of capital. It will destroy value as it grows.
For a comprehensive WACC calculation, please access the WACC Calculator.
Dingdang Health Technology Group (HKSE:09886) WACC % Explanation
Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Dingdang Health Technology Group's weighted average cost of capital is 5.4%%. Dingdang Health Technology Group's ROIC % is -4.58% (calculated using TTM income statement data).
Dingdang Health Technology Group earns returns that do not match up to its cost of capital. It will destroy value as it grows.
Be Aware
1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest one-year semi-annual average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
For companies that report quarterly, GuruFocus combines all of the most recent year's quarterly debt data from the beginning of the year to the year-end and calculates the average.
For companies that report semi-annually, GuruFocus combines all of the most recent year's semi-annual debt data from the start of the year to the year-end and calculates the average.
For companies that report annually, GuruFocus combines the beginning and ending annual debt data from the most recent year and then calculates the average.
2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.
3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
4. GuruFocus uses the latest TTM Interest Expense divided by the latest one-year semi-annual average debt to get the simplified cost of debt.
Related Terms
Dingdang Health Technology Group WACC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Dingdang Health Technology Group's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Dingdang Health Technology Group WACC % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Dingdang Health Technology Group's WACC % distribution charts can be found below:
* The bar in red indicates where Dingdang Health Technology Group's WACC % falls into.
Dingdang Health Technology Group WACC % Calculation
The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.
WACC
=
E
/
(E + D)
*
Cost of Equity
+
D
/
(E + D)
*
Cost of Debt
*
(1 - Tax Rate)
1. Weights:
Generally speaking, a company's assets are financed by debt and equity. We need to calculate the weight of equity and the weight of debt.
The market value of equity (E) is also called "Market Cap". As of today, Dingdang Health Technology Group's market capitalization (E) is HK$1016.248 Mil.
The market value of debt is typically difficult to calculate, therefore, GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding the latest one-year semi-annual average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together. As of Jun. 2026, Dingdang Health Technology Group's latest one-year semi-annual average Book Value of Debt (D) is HK$300.5873 Mil.
a) weight of equity = E / (E + D) = 1016.248 / (1016.248 + 300.5873) = 0.7717
b) weight of debt = D / (E + D) = 300.5873 / (1016.248 + 300.5873) = 0.2283
2. Cost of Equity:
GuruFocus uses Capital Asset Pricing Model (CAPM) to calculate the required rate of return. The formula is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
a) GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate. It is updated daily. The current risk-free rate is 4.658%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default.
b) Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. Dingdang Health Technology Group's beta is 0.1386.
c) (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
Cost of Equity = 4.658% + 0.1386 * 6% = 5.4896%
3. Cost of Debt:
GuruFocus uses latest TTM Interest Expense divided by the latest one-year semi-annual average debt to get the simplified cost of debt.
As of Jun. 2026, Dingdang Health Technology Group's interest expense (positive number) was HK$15.385 Mil. Its total Book Value of Debt (D) is HK$300.5873 Mil.
Cost of Debt = 15.385 / 300.5873 = 5.1183%.
4. Multiply by one minus TTM Tax Rate:
GuruFocus uses the most recent TTM Tax Expense divided by the most recent TTM Pre-Tax Income to calculate the tax rate. The calculated TTM tax rate is limited to between 0% and 100%. If the calculated tax rate is higher than 100%, it is set to 100%. If the calculated tax rate is less than 0%, it is set to 0%.
The latest calculated TTM Tax Rate = 22.309 / -52.859 = -42.2%, which is less than 0%. Therefore it's set to 0%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Dingdang Health Technology Group (HKSE:09886) has a WACC % of 5.4% as of Aug. 27, 2026. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Dingdang Health Technology Group and its competitors. This is 44% below median its historical median of 9.63. Over the past decade, Dingdang Health Technology Group's WACC % has ranged from 5.45 to 11.97. According to the industry distribution chart, Dingdang Health Technology Group ranks #200 out of 692 companies in the Healthcare Providers & Services industry, placing it in the top 28.9%.
Is Dingdang Health Technology Group's WACC % too high?
Dingdang Health Technology Group's current WACC % of 5.4% is 44% below median its 10-year median of 9.63. Over the past 10 years, this metric has ranged from a low of 5.45 to a high of 11.97. The Healthcare Providers & Services industry median WACC % is 8.33. Dingdang Health Technology Group's value of 5.4% is 35.1% below this industry median. Based on the distribution chart, Dingdang Health Technology Group ranks #200 out of 692 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Dingdang Health Technology Group has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Dingdang Health Technology Group's WACC % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Dingdang Health Technology Group ranks #200 out of 692 companies for WACC %. This puts Dingdang Health Technology Group in the upper half of its industry. The industry median WACC % is 8.33. Dingdang Health Technology Group's value of 5.4% is 35.1% below this benchmark. Historically, Dingdang Health Technology Group's own WACC % has ranged from 5.45 to 11.97 over the past decade. While the company's 10-year median is 9.63 vs. the industry median of 8.33, Dingdang Health Technology Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good WACC % for a Healthcare Providers & Services company?
The median WACC % among Healthcare Providers & Services companies is 8.33, based on 692 companies in the industry. Companies in the top quartile (top 25%) have a WACC % significantly above this median, while those in the bottom quartile fall well below. However, WACC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Dingdang Health Technology Group's current WACC % of 5.4% is 35.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high WACC % mean?
A high WACC % can signal that a stock is expensive relative to its fundamentals. The weighted average cost of capital (WACC) is the average rate a company pays to finance assets. View historical data on Dingdang Health Technology Group and its competitors. For the Healthcare Providers & Services industry, the median WACC % is 8.33 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Dingdang Health Technology Group's current WACC % is 5.4%, which is 44% below median its own 10-year median of 9.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Dingdang Health Technology Group stock overvalued right now?
Based on GuruFocus' analysis, Dingdang Health Technology Group (HKSE:09886) is currently considered Possible Value Trap. The stock's GF Value™ is HK$1.44, compared to a current price of HK$0.82 — trading 43.1% below its estimated fair value. The current WACC % is 5.4%, which is 44% below median its 10-year median of 9.63 and 35.1% below the Healthcare Providers & Services industry median of 8.33. Dingdang Health Technology Group's overall GF Score™ is 68/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is WACC % calculated?
WACC % is calculated from a company's financial statements. For Dingdang Health Technology Group (HKSE:09886), the current WACC % is 5.4% as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Dingdang Health Technology Group (HKSE:09886) Overvalued in 2026?
Based on GuruFocus' analysis, Dingdang Health Technology Group stock appears to be undervalued.
The current stock price of HK$0.82 is trading 43.1% below its estimated GF Value™ of HK$1.44.
GuruFocus considers Dingdang Health Technology Group to be Possible Value Trap.
Key valuation signals for HKSE:09886:
WACC %: 5.4% (44% below median its 10-year median of 9.63)
GF Value™: HK$1.44 vs. price of HK$0.82 (43.1% below fair value)
Industry Position: 35.1% below the Healthcare Providers & Services median (#200 of 692)
No single metric tells the full story. See the HKSE:09886 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Dingdang Health Technology Group Ltd is an investment holding company and its subsidiaries are principally engaged in the provision of pharmaceutical and healthcare business in the PRC. It is transforming and reshaping China's healthcare industry by pioneering on-demand pharmaceutical retail and medical consultation, with online-to-offline solutions. All of the company's revenue is generated from the PRC.
68GF Score
Get the complete analysis for HKSE:09886
WACC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09886 has been successfully added to your 
